Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06427590 Org: User:
Start: 07/13/24 End: 12/31/24 Due: 12/31/25

A Study to Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

Phase: N/A Priority: Normal
NCT ID: NCT07002905 Org: User:
Start: 06/30/25 End: 01/31/26 Due: 01/31/27

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of ASC30 Tablets and ASC30 Tablets A1 in Participants With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06680440 Org: User:
Start: 08/26/24 End: 04/03/25 Due: 04/03/26

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT07024602 Org: User:
Start: 06/30/25 End: 06/30/26 Due: 06/30/27

A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Combination With Semaglutide

Phase: N/A Priority: Normal
NCT ID: NCT06972992 Org: User:
Start: 04/18/25 End: 12/18/25 Due: 12/18/26

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ASC30 Injection in Participants With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT06679959 Org: User:
Start: 09/16/24 End: 04/30/26 Due: 04/30/27